TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN MEDULLOBLASTOMA

被引:0
|
作者
Richardson, Angela M. [1 ,2 ]
Collins, Sara A. [3 ]
Inagaki, Akihito [3 ]
Armstrong, L. [4 ]
Roussel, Martine [5 ]
Jolly, Douglas [6 ]
Robbins, David J. [7 ,8 ]
Ayad, Nagi [9 ]
Kasahara, Noriyuki [10 ,11 ]
机构
[1] Univ Miami, Dept Neurol Surg, Miami, FL USA
[2] Jackson Hlth Syst, Neurosurg Program, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[4] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[5] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[6] Tocagen Inc, San Diego, CA USA
[7] Univ Miami, Dept Surg, Miami, FL USA
[8] Univ Miami, Dept Biochem, Miami, FL USA
[9] Univ Miami, Miami, FL USA
[10] Univ Miami, Dept Cell Biol, Miami, FL USA
[11] Univ Miami, Dept Pathol, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PDTM-19
引用
收藏
页码:193 / 193
页数:1
相关论文
共 50 条
  • [1] TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN CNS METASTATIC BREAST CANCER
    Inagaki, Akihito
    Richardson, Angela M.
    Collins, Sara A.
    Hiraoka, Kei
    Kamijima, Shuichi
    Shorr, Jolene
    Gruber, Harry
    Jolly, Douglas
    Merchan, Jaime
    Slingerland, Joyce M.
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2017, 19 : 257 - 257
  • [2] Toca 511 and Toca FC in patients with gastrointestinal tumors in the Toca 6 study.
    Merchan, Jaime R.
    Ostertag, Derek
    Jolly, Douglas J.
    Tejera, Dalissa
    Gruber, Harry E.
    Shorr, Jolene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Prior Radiation in Subjects Who Were Treated With Toca 511 and Toca FC Across 3 Toca 511 Phase 1 Trials
    Cloughesy, T. F.
    Aghi, M.
    Bota, D.
    Chen, C.
    Elder, J. B.
    Kalkanis, S. N.
    Kaptain, G. J.
    Kesari, S.
    Landolfi, J.
    Mikkelsen, T.
    Portnow, J.
    Robbins, J. M.
    Ostertag, D.
    Chu, A.
    Huang, T.
    Vogelbaum, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E66 - E67
  • [4] Therapeutic Activity of Gene Therapy with Toca 511 & Toca FC for Esophageal Cancer
    Suzuki, Tomohiro
    Hiraoka, Kei
    Inoko, Kazuho
    Inagaki, Akihito
    Sasaki, Katsunori
    Kushiya, Hiroki
    Umemoto, Kazufumi
    Sato, Osamu
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Boyle, Nicholas A.
    Jolly, Douglas J.
    Gruber, Harry E.
    Kasahara, Noriyuki
    Hirano, Satoshi
    MOLECULAR THERAPY, 2019, 27 (04) : 132 - 133
  • [5] Antitumor cellular immune response elicited by Toca 511 and Toca FC therapy in preclinical and clinical studies
    Montellano, Tiffany T.
    Ostertag, Derek
    Hogan, Daniel J.
    Diago, Oscar R.
    Gammon, Dawn
    Haghighi, Ali
    Accomando, William
    Mitchell, Leah
    Das, Asha
    Gruber, Harry
    Jolly, Douglas J.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [6] Immune modulation after Toca 511 and Toca FC treatment of colorectal cancer patients
    Falchook, Gerald Steven
    Ahnert, Jordi Rodon
    Venkat, Shree
    Donahue, Arthur
    Horner, Peder
    Thomassen, Amber
    Accomando, William
    Rodriguez-Aguirre, Maria
    Bentley, Cornelia
    Hogan, Daniel
    Ostertag, Derek
    Yavrom, Sharon
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Shorr, Jolene
    Merchan, Jaime R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] Encouraging survival with Toca 511 and Toca FC compared to external lomustine control.
    Cloughesy, Timothy Francis
    Aghi, Manish K.
    Chen, Clark
    Elder, J. Bradley
    Kesari, Santosh
    Kalkanis, Steven N.
    Kaptain, George
    Landolfi, Joseph C.
    Mikkelsen, Tom
    Portnow, Jana
    Robbins, Joan M.
    Ostertag, Derek
    Das, Asha
    Chu, Alice
    Vogelbaum, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Toca 511 Followed by Toca FC in Subjects with Recurrent High Grade Glioma (HGG)
    Aghi, Manish K.
    Vogelbaum, Michael
    Cloughesy, Timothy
    Kesari, Santosh
    Portnow, Jana
    Ostertag, Derek
    Keller, Mary Rose
    Chu, Alice
    Skillings, Jamey
    Kaptain, George
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : A1154 - A1154
  • [9] Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma
    Philbrick, Brandon D.
    Adamson, D. Cory
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (03) : 207 - 216
  • [10] TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Cloughesy, Timothy
    Petrecca, Kevin
    Walbert, Tobias
    Butowski, Nicholas
    Salacz, Michael
    Perry, James
    Damek, Denise
    Bota, Daniela
    Bettegowda, Chetan
    Zhu, Jay-Jiguang
    Iwamoto, Fabio
    Placantonakis, Dimitris
    Martinez, Nina
    Elder, J. Bradley
    Kaptain, George
    Cachia, David
    Moshel, Yaron
    Brem, Steven
    Picconi, David
    Nam Tran
    Nam, Do-Hyun
    Park, Chul-Kee
    Landolfi, Joseph
    Tran, David
    Ramakrishna, Rohan
    Fink, Karen
    Heros, Deborah
    Zadeh, Gelareh
    Nicholas, Garth
    Mehta, Vivek
    Robins, H. Ian
    Chen, Clark
    Pitz, Marshall
    Heth, Jason
    Nagpal, Seema
    Pearlman, Michael
    Ahluwalia, Manmeet
    Mohile, Nimish
    Merrell, Ryan
    Schiff, David
    Thompson, Reid
    Davis, Raphael
    Macdonald, David
    Kheoh, Thian
    Kabbinavar, Fairooz
    Lossos, Alexander
    Vogelbaum, Michael
    NEURO-ONCOLOGY, 2019, 21 : 284 - 284